Abbott Laboratories (ABT) Intangibles (2009 - 2026)

Abbott Laboratories has disclosed Intangibles across 18 years of filings, most recently posting $17.2 billion for Q2 2026.

• In Q2 2026, Intangibles rose 190.73% year-over-year to $17.2 billion; the TTM figure through Jun 2026 stood at $17.2 billion (up 190.73% YoY), while the FY2025 annual figure was $5.5 billion, down 16.86% from the prior year.
• Intangibles came in at $17.2 billion for Q2 2026 at Abbott Laboratories, down from $17.9 billion in the prior quarter.
• In the past five years, Intangibles ranged from a high of $27.7 billion in Q1 2022 to a low of $5.5 billion in Q4 2025.
• Average Intangibles over 5 years is $10.4 billion, with a median of $9.0 billion recorded in 2023.
• Year-over-year, Intangibles sank 63.88% in 2023 and surged 190.73% in 2026.
• Over 5 years, Intangibles stood at $10.5 billion in 2022, then declined by 15.68% to $8.8 billion in 2023, then slipped by 24.59% to $6.6 billion in 2024, then decreased by 16.86% to $5.5 billion in 2025, then surged by 211.45% to $17.2 billion in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $17.2 billion in Q2 2026, $17.9 billion in Q1 2026, and $5.5 billion in Q4 2025.